Rolipram, a phosphodiesterase 4 inhibitor, prevented cancellous and cortical bone loss by inhibiting endosteal bone resorption and maintaining the elevated periosteal bone formation in adult ovariectomized rats.
Year: 2007
Type: article
Source: PubMed
Authors: W Yao, X Y Tian, J Chen, R B Setterberg, M W Lundy, P Chmielzwski, C A Froman, W S S Jee
Institutions: University of Utah, Procter & Gamble (United States)
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2397019667